HGH Fragment 25 mg

About HGH Fragment

HGH Fragment (176–191) represents the specific C-terminal domain of growth hormone responsible for lipid-mobilizing properties. Unlike full-length somatotropin, HGH Fragment acts without competing for GH receptors, avoiding hyperglycaemic, mitogenic, and IGF-1 elevating pathways while actively triggering lipolytic cascades in adipocytes.

Pen technology & delivery format

HGH Fragment is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, 3 mL dial-calibrated laboratory dispensing system engineered to eliminate reconstitution variability, aerosolization, and volumetric measurement errors in repeat-dose research designs. Each pen is pre-filled with ≥99% HPLC-authenticated research peptide solution, features a tactile dial-a-dose click mechanism, and is preserved under 2–8 °C cold-chain storage with a verifiable batch Certificate of Analysis.

Handling & research compliance

This pre-filled pen is intended strictly for in-vitro and laboratory research use by qualified scientific investigators. It is not an approved medicine, medical device, food, or supplement, and is not for human or veterinary use, ingestion, or injection. Store refrigerated at 2–8 °C, protect from direct light, and follow accepted laboratory safety procedures. Statements have not been evaluated by any regulatory authority (FDA, EMA).